Revvity (RVTY) Net Cash Flow Growth (1y) (2010 - 2026)
Revvity (RVTY) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 498.33% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -260.86% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -86.40% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 722.22% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -115.29% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 73.93% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 73.12% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -441.96% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -424.43% |
| 10 | Revvity | 14.41 Bn | 13.39 Bn | 416.87 Mn | 188.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 5, 2026 | 188.37% |
| Apr 5, 2026 | 8.91% |
| Dec 28, 2025 | 57.53% |
| Sep 28, 2025 | -258.01% |
| Jun 29, 2025 | -167.44% |
| Mar 30, 2025 | -146.74% |
| Dec 29, 2024 | 29.86% |
| Sep 29, 2024 | 85.63% |
| Jun 30, 2024 | 129.41% |
| Mar 31, 2024 | -94.68% |
| Dec 31, 2023 | 77.19% |
| Apr 2, 2023 | 1,636.89% |
| Apr 3, 2022 | -82.35% |
| Oct 3, 2021 | -802.77% |
| Jul 4, 2021 | -1,449.29% |
| Apr 4, 2021 | 4,323.07% |
| Jan 3, 2021 | 123.44% |
| Oct 4, 2020 | -86.70% |
| Jul 5, 2020 | 24.03% |
| Apr 5, 2020 | 145.87% |